Business Wire·Nov 10, 2026, 8:00 AM ET

Imperative Care Announces Two New Board of Directors Appointments

Imperative Care appointed Brett Wall, former president of Medtronic's neuroscience portfolio, and Dr. Josh Makower, co-founder of Stanford's Mussallem Center for Biodesign, to its board of directors.
Wall joins as an independent director with over two decades of experience in neurovascular & neuroscience businesses, including leadership roles at Micro Therapeutics, ev3, Covidien, & Medtronic.
Makower joins as the representative for Elevage Medical Technologies, replacing Dr. Evan Melrose, & brings expertise from founding medical device companies & holding over 300 patents.
Fred Khosravi, chairman & CEO of Imperative Care, highlighted Wall's authority in neuroscience businesses & Makower's success in turning innovative concepts into successful companies.
John Hamre, chairman of the nominating & governance committee, stated the new directors will strengthen the board's ability to guide growth & advance the mission of democratizing vascular thrombectomy.
Holly Sheffield stepped down from the board after five years of service, with Khosravi thanking her for her pivotal contributions.
Imperative Care is a Silicon Valley-based medical technology company focused on treating thromboembolic disease, with a commercial portfolio including the Zoom, Symphony, & Prodigy Thrombectomy Systems.
The company is developing the Telos Robotic Platform to enhance precision & standardization in procedures, though it is currently not cleared or approved for sale.